Skip to content
lifestyle.theroguemag.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Celularity Inc.
Celularity Announces Over $10 Million Initial Financing Closing as Part of Up to $28 Million Recapitalization to Accelerate Growth Following Significant Operating Improvements
September 24, 2026
Celularity Provides Update Regarding Nasdaq Listing Compliance
September 4, 2026
Celularity and Fountain Life Announce Availability of Cenplacel-L for Investigational Use Under New Florida Law, Establishing Scalable Pathway for Advancement of Placental-Derived Cell Therapies
June 4, 2026
Celularity Releases CEO Letter to Shareholders
June 3, 2026
Celularity Appoints Rick Gonzalez as Chief Commercial Officer
June 3, 2026
Celularity Receives Nasdaq Notice Regarding Form 10-Q
May 29, 2026
Celularity Announces Filing of Form 10-K, Regains Nasdaq Compliance and Highlights Continued Strategic Transformation
May 22, 2026
Celularity Announces Closing of Transaction with NexGel
April 21, 2026
Celularity Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing
April 17, 2026
Celularity Receives $12.2 Million from Sale of New Jersey Net Operating Losses
February 11, 2026